journal article Open Access May 04, 2023

Evaluation of 2,3-Dihydro-1,5-benzothiazepine Derivatives as Potential Tyrosinase Inhibitors: In Vitro and In Silico Studies

ACS Omega Vol. 8 No. 19 pp. 17195-17208 · American Chemical Society (ACS)
View at Publisher Save 10.1021/acsomega.3c01566
Topics

No keywords indexed for this article. Browse by subject →

References
58
[2]
Natural, semisynthetic and synthetic tyrosinase inhibitors

Sang Yeul Lee, Namhuk Baek, Tae-Gyu Nam

Journal of Enzyme Inhibition and Medicinal Chemist... 10.3109/14756366.2015.1004058
[25]
Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations

Brayan Roulier, Basile Peres, Romain Haudecoeur

Journal of Medicinal Chemistry 10.1021/acs.jmedchem.0c00994
[33]
Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry

Minghao Feng, Bingqing Tang, Steven H. Liang et al.

Current Topics in Medicinal Chemistry 10.2174/1568026615666150915111741
[48]
Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase

Zaman Ashraf, Muhammad Rafiq, Sung-Yum Seo et al.

European Journal of Medicinal Chemistry 10.1016/j.ejmech.2015.05.031

Showing 50 of 58 references

Metrics
30
Citations
58
References
Details
Published
May 04, 2023
Vol/Issue
8(19)
Pages
17195-17208
License
View
Authors
Funding
Higher Education Commission, Pakistan Award: NRPU-15800
United Arab Emirates University Award: G00003918
Umm Al-Qura University Award: 23UQU4320545DSR001
Cite This Article
Munirah M. Al-Rooqi, Amina Sadiq, Rami J. Obaid, et al. (2023). Evaluation of 2,3-Dihydro-1,5-benzothiazepine Derivatives as Potential Tyrosinase Inhibitors: In Vitro and In Silico Studies. ACS Omega, 8(19), 17195-17208. https://doi.org/10.1021/acsomega.3c01566